HC Wainwright & Co. Reiterates Buy on HeartBeam, Maintains $5.5 Price Target
3/16/2026
Impact: 70
Healthcare
HC Wainwright & Co. analyst Yi Chen has reiterated a 'Buy' rating on HeartBeam (NASDAQ: BEAT) and maintained a price target of $5.5 for the stock.
AI summary, not financial advice
Share: